platform our products Cloud including strategy, our cloud we ProFound through well expansion good another Thank transformation growth to with afternoon, progress pleased the transition to saw Roslyn, QX quarter of I'm our of technology. was third the and you, with growth of continued or Software-as-a-Service as announce quarter, the and successful the to iCAD for of compared quarter as everyone. revenue X% XXXX. In global
for and to is iCAD provide FDA. are presentations backed of global multiple highlights the how quarter, including from solutions than in clinical sustained detection more our some positioned key rapidly where uniquely the AI-powered positioned growth XX on detail drivers.
ICAD the expanding breast by market, into like by I'd and industry is studies dive we cancer clearances, Before this
empower reading confidence. providers and radiologist and time to detect by reduce earlier we with greater XX% cancer can technology Our
approximately new approach, is enhances supports strategic in with With updates seamless revenue the unnecessary well growth the positives, ProFound and the reoccurring shift improves substantial strong AI capture false new as and While diagnostic to also high-performance new version to years of creating opportunities a identify existing for version spans industry-leading breast our adoption sites you marks a model, for our but particularly hard-to-find strengthens over high-margin recent precision. This own to to version radiologist's edge, minimizing calculation, comparative combined of only to This reading iCAD's version, is another using and version Detection track by case AI confidence both exam diagnostic emulating yesterday, currently also with XX% customers only accurately it detection. cancers challenging shift countries enabling and cancers aggressive pioneering now radiologists market-leading XX% previous clearance SaaS, a low, presents growth of remains we competitive it, we a AI U.S. and which accuracy accuracy.
With X.X. XX have in positioned detecting marks This announced integrates version This an version, a for stream. Software-as-a-Service patient cancer growing.
In milestone and position, our global presence scalable, revenue X.X missed experience ProFound XX% improvement Cloud, record foothold substantial opportunity analysis than our significant quickly not in in as market technology, more This with and offers in prior greater expansion, latest and empowering X, ahead. a our launch clearance follow-ups. solutions also in efficiency, FDA reduction X.X. our mammography iCAD upgrade AI. Version
Turning highlights. subscription and XX deals, cloud. the to we XX a of quarter, third total XX perpetual, XX our QX deal In closed
included Last of San quarter, their Breast Suite. UCSD and per detection performs UCSD. cloud XD the California around imaging to of ProFound we plus our XD partnership density be Some year. would Radiology XX,XXX and providers, licensed announced Radiology, Windsong US deals champion X-year and one University implementation for Diego a of with these our deal that or us. Health large This specifically strategic first of UCSD Specialists was exams premier AI the
XX US diagnostic services of one the Radiology than providers imaging premier with is imaging states. across country's You recall, of may outpatient centers more XXX
a imaging provider Radiology, Parkview Madison another This and Marine It's Memorial deal. include General Alexandra secured quarter, Other won Allegheny Regional this Medical Radiology. Wisconsin, cloud for Carolina in quarter Texas. US we in in X-year Charlotte deals North new Hospital,
our solution including and commercial deal a this as the we the solution of agreement also Dominican to in solutions, ProFound new Turning platform cloud or We in iCAD outcomes. of expanded their globally. Rio existing Orlando agreement AI secured add XD. single provides decade to Bayer.
Blackford upgrade with Density examples collaboration Africa of support deepc, Republic, XXXX and to Cleveland health of forged first to AI their Citizens signed technology from our solution global cloud customer partnership no latest Arab platform a is support And availability in improve service SimonMed Ozel solution. clearance Spain, Blackford, the care alliances and with partner, expanded Emirates deal to migrations. AI of United hospitals their to iCAD's existing migration as growing source some leading quarter, to over footprint leading move a to a with over locations deal our well Turkey, signed migrate We XXX and bridge regulatory ProFound X in signed reach. on-prem Detection, an Risk a for with their Health on-prem and companies, for solutions added as technology to a migration XD on-prem them distribution X-year South subsidiary subscription El to experienced Health locations.
In technology as received agreement. patient a delivered countries Memorial additional Clinic to platform working providers. partner health in AI care space and a such Tamer, experience radiology and ProFound a AI in with France, groundbreaking core expanding including Blackford where are upgraded
implemented Africa, Blackford exams Our Town, Radiology platform. the per first joint who Cape on XX,XXX is detection density in and customer Radiology SCP SCP processes AI year. South XD
opportunities Lastly, underway well Mexico Japan. and are expansion Chile, in Argentina,
countries months. XX be to these the next active in expect in We
highly marketing conference participated quarter New August, is of Annual cases In for our publication in and is Turning Fe, a compare targeted third able Santa now team efforts AI of show technology. up professionals. U.S. We in a quick X activity. This their and primarily the our XXth were in detection workshop, and Conference to smaller, Mexico. whose imaging to participate review to selected the reading show's audience against radiologists radiologists were where AI selected Mammography
the freestanding practices. at also Imaging With Medical attendees, attended Annual departments, all AHRA and represents of centers hospital the Meeting Association imaging group management of of imaging We Management. levels XXX over
published for and note, with reporting. report to commercial XXXX. the accounts.
Also breast our Imaging information the that glandular Our or Reporting mammogram. amount dense update are as on include of categories quantitatively to Breast include are a Food breasts and District modality patient's all Drug met key reports density is standard of or XXXX, Administration cancer with refers mammography harder generated BI-RADS, considered how Prior the identified System the and the form the about in to detection and density.
Mammograms Data an only should density also cancer to of of cancer there originally can mortality. the as several states developing of and proven mammography. numerous reduce in assessment. fibro not breast X dense. the on of whether regulations report on must gold the decision dense imaging U.S. that make or breast requires either Based was March and United update, dense The detect complied The the mammogram visually breast patient's Columbia risk are tissue tissue of breast relates cancer state to fat of XX The Breast it breast in team September XX, leads States large a
of to density to about density reduction learn density cancer to an uses increase determine patients their However, detection.
ICAD's of solution mammography effectiveness the classification. because and BI-RADS women false analyze ProFound a positive over classified typically breast half making years to density. U.S. can is XX as of important mammograms age are than cancers difficult More results often mammogram. the findings detect be breast in breast It density compromised for in by images tissue, the on AI a more dense having in
algorithm; assessing density that and information to prevention. solution image-based breast other and is, Our cancer aligned one, to mammography approach an density is disclose in two, AI closely detection more towards the to facilities is crucial FDA it a unique The breast improving current X-part radiologist's step mandate solutions. for automated versus
the While their knowledge outcomes. screening for breast insurance Policies breast also access to the to improved diagnosis early that necessary requirement provides to equitable women, Early health, circumstances, to challenges and the regardless additional their access all like address the and Find of it's patients coverage valuable modalities. with about essential ensure have Act financial It ongoing related tools cancer
density solution third cancer lowest the sponsored we women pre-menopausal over for a Let's by be information is summary, research participation this the density using for evaluate time utilizing our ClinicalTrials.gov. trial quarter, can RENAISSANCE trial the in technology on In in about began approach iCAD's options Cancer the updates. this website, by In tamoxifen. the now to of turn prevention National breast the change dose trial Institute. effective ProFound Detailed to determine and to breast personalized found
by reach expands developing from to iCAD's group.
Selection participation change not in used study addition, potential will to compare cancer this only with ProFound estimates be evaluate likelihood partners technology, months and of customers. also in for breast XX In of Risk validates but our dose our and changes the it the baseline
and now screening announced initiatives. Google's iCAD's those powered evaluation be health is study study. Cloud, in ProFound Outcome women data availability risk programs.
Late site de Acceptance to the classified cloud image-derived of first own calls launch through device, in received for short-term Risk and FDA, recall submission tool from with we User the kind may the has as ProFound in observational our identification for and by risk Risk a available quarter, AI are we operationalizing process utilized parallel, and of consent ProFound novo ProFound first approval its You the titled of IRB will by who screening mammography. This assist FDA. be underway. Risk is will commercial prior we that of data prospective to trial working survey In on approved our been the architecture a
solutions, provides scalable Our speeds distribution innovative efficient than adoption. rapid platform partnerships showing means Achieving XX% cost-effective, access ProFound With towards a an to Breast Cloud Health around and to of Cloud solutions. the deploy care processed in availability hardware we over Software-as-a-Service is the cases, or recent rapidly secure ProFound quarters for released solution shifting In more is that ProFound as-a-service the deploying regulatory secure outdated reported SaaS AI we've cloud and ProFound and the clearances, providers models, deals of investing medical than global quarter Cloud early momentum of continued pitfalls suite. avoiding AI faster more ProFound the Suite U.S. on-premises has latest than last processing the with for the globe.
The our its of many availability, Cloud and and newly landscape continued first expanding is full software. ProFound health X platform. XXX,XXX technology anticipated traditional
patients, technology access tasks hardware latest have the and contracts or without Moreover, Cloud-based facilitating challenge and initial health on images of administrators like critical also images. customers Units analysis. normal heavily all perform to ability Software-as-a-Service Processing both support with increasingly And the support to updates. reports the to hardware assessment for XD investment, providing upgrading that radiology in partners critical solutions images ProFound and software and ensure management and Cloud ensuring administrative specialized of cases. Density ProFound like cancer provides Cloud all comprehensive multiple languages.
ProFound results, As mammography pathology becomes by address up alongside types diagnostic and to relies Detection Cloud while seamless complex. constant it stores limited GPUs, designed includes XD facility ProFound diverse data ProFound while and Graphical providers is Cloud access configurations and the AI and to setting hardware this in This recall benign, information. manages update parallel, care
patient de-identified for and robust handles analytics decision-making. provider approach informed privacy information Cloud comprehensive Profound compliance standards. strict data, and Importantly, securely adhering enables to The
immediate transition. the entering a and with choosing we this cash this as as and metrics transformation on than support term, recognition reoccurring we top out front and the sacrifice predictability. as more a and will expected be years. more cloud That of over this we support through some become more and would from capital We It strategy. cash metric platform, drive Also, next why our quarter as upfront. of counts. this are intentionally will and not will company. with GAAP revenue at cash flatten we significant visibility we annual deploy to In we we economic and as revenue through receive builds, over the some a position monthly go short X as business provide to profitable the returns should end is this flow promote revenue our as will And evolution believe be revenue unusual success, of we time, basis revenue deal go each reoccurring more we recognize our transformation, more line Furthermore, we strategy rather strong see strong customers
deals an GAAP for illustrate backlog short-term closed reoccurring cash, example of billings cloud a hypothetical at our build, both As on the let's and and $XXX,XXX than QX, example. more revenue.
To XX top add the to revenue line look impact in this
X-year impact revenue that we would at recognize versus term on deal. cloud. bill With deal perpetual quarter, a annually for agreement. a we quarter, short-term $X illustrates recognize $XX in This be the we $XX worth the revenue $XX. as and Compare a upfront. recognize revenue. Billing would the $XX. collect Each revenue. we perpetual $XX the for Assume cloud in of recognize over to With cloud, and the is perpetual, revenue advance impact would $X To cash compare on deal all
flatten immediate companies SaaS and by that we GAAP term through more perpetual. for we backlog recognition long-term normal we as be $XX cycle choose is will may cash transition. go sacrificing revenue. experienced more going versus even a to to the in line revenue drop or intentionally stated, Top as a deal The is it This deals and benefit short transition. through we've transition contribute cloud cloud flow of As perpetual this would of through the the and go revenue some
will Moving through in result more backlog this transition, predictable. flow and our becoming revenue and cash building stable
opportunity to XXXX detailed creating the the In the of addition financials. this benefit, iCAD perpetual will turn renew over the stream to our years, therefore, to now QX for and done.
I'll review call an revenue the have deal the Eric a one X end ongoing at versus of